This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Ju Ryoung Kim: Innovator in Pharmaceutical Composition
Introduction: Ju Ryoung Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical compositions and health foods. His work focuses on innovative solutions for preventing and treating cardiovascular diseases.
Latest Patents: Ju Ryoung Kim holds 1 patent. His patent relates to a pharmaceutical composition and health food comprising PL3 extract or phellinsin A isolated from the same as an effective component. This invention specifically addresses the inhibition of low-density lipoprotein (LDL) oxidation. Furthermore, it highlights the potential of PL3 extract and phellinsin A as components for medicine and food to effectively prevent and treat cardiovascular diseases such as hyperlipidemia and arteriosclerosis.
Career Highlights: Ju Ryoung Kim is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to explore and develop innovative health solutions. His research has the potential to impact the pharmaceutical industry significantly.
Collaborations: Ju Ryoung Kim has collaborated with notable colleagues, including Sung Uk Kim and Eui Il Hwang. These partnerships have contributed to the advancement of his research and innovations.
Conclusion: Ju Ryoung Kim is a prominent inventor whose work in pharmaceutical compositions is paving the way for advancements in cardiovascular health. His contributions are essential in the ongoing fight against heart-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
